Position in SRPT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$20,151,162
-$16,080,935 QoQ
Shares Held
1,121,378
-32.7% QoQ
Ownership
1.06%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#21
of 323 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. SRPT ranks #36 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in SRPT
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,151,162 | 1,121,378 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $36,232,097 | 1,665,078 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $24,954,118 | 1,159,578 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $51,068,930 | 2,650,178 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $10,678,573 | 624,478 | Shares | Sole | 2025-08-13 | |
| 2024-09-30 | $28,784,397 | 230,478 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $55,616,000 | 352,000 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $50,525,389 | 390,278 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $54,287,968 | 562,978 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $82,778,471 | 682,878 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $73,530,772 | 642,078 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $111,156,862 | 806,478 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $93,152,211 | 718,878 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $97,737,036 | 884,178 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $29,480,118 | 393,278 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $11,624,256 | 148,800 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $21,213,798 | 235,578 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $786,080 | 8,500 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $9,949,009 | 127,978 | Shares | Sole | 2021-08-13 | |
| 2020-09-30 | $21,988,248 | 156,578 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $73,191,682 | 456,478 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $7,794,101 | 79,678 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||